Cargando…
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
Dengue virus (DENV) is responsible for approximately 100 million cases of dengue fever annually, including severe forms such as hemorrhagic dengue and dengue shock syndrome. Despite intensive vaccine research and development spanning several decades, a universally accepted and approved vaccine again...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466046/ https://www.ncbi.nlm.nih.gov/pubmed/37654495 http://dx.doi.org/10.3389/fimmu.2023.1208041 |